Page 18 - 《中国药房》2025年19期

[99] VANDENBROUCKE J P，VON ELM E，ALTMAN D G， collected data （CONSORT-ROUTINE）：checklist with
et al. Strengthening the reporting of observational studies explanation and elaboration[J]. BMJ，2021，373：n857.
in epidemiology （STROBE）：explanation and elaboration [113] VLAHOV D. Transparent reporting of evaluations with
[J]. Int J Surg，2014，12（12）：1500-1524. nonrandomized designs （TREND）[J]. J Urban Health，
[100] BENCHIMOL E I，SMEETH L，GUTTMANN A，et al. 2004，81（2）：163-164.
The reporting of studies conducted using observational [114] PAGE M J，MCKENZIE J E，BOSSUYT P M，et al. The
routinely-collected health data （RECORD） statement[J]. PRISMA 2020 statement：an updated guideline for repor-
PLoS Med，2015，12（10）：e1001885. ting systematic reviews[J]. BMJ，2021，372：n71.
[101] 聂晓璐，武泽昊，赵厚宇，等. 使用常规收集医疗卫生数 [115] ZHANG X，TAN R，LAM W C，et al. PRISMA （preferred
据开展观察性研究的报告规范（药物流行病学版） reporting items for systematic reviews and meta-analyses）
RECORD-PE 规范中文版：上[J]. 药物流行病学杂志， extension for Chinese herbal medicines 2020 （PRISMA-
2019，28（3）：190-198，212. CHM 2020）[J]. Am J Chin Med，2020，48（6）：1279-1313.
[102] 聂晓璐，武泽昊，赵厚宇，等. 使用常规收集医疗卫生数 [116] WANG X Q，ZHOU Q，CHEN Y L，et al. Protocol of re‐
据开展观察性研究的报告规范（药物流行病学版） porting items for public versions of guidelines：the repor-
RECORD-PE 规范中文版：下[J]. 药物流行病学杂志， ting tool for practice guidelines in health care：public ver‐
2019，28（4）：263-272. sions of guidelines[J]. BMJ Open，2019，9（3）：e023147.
[103] GAGNIER J J，KIENLE G，ALTMAN D G，et al. The [117] HUSEREAU D，DRUMMOND M，AUGUSTOVSKI F，
CARE guidelines：consensus-based clinical case reporting et al. Consolidated health economic evaluation reporting
guideline development[J]. BMJ Case Rep，2013，2013： standards 2022 （CHEERS 2022） statement：updated re‐
bcr2013201554. porting guidance for health economic evaluations[J].
[104] 于河，杨红，刘建平. 专家临证验案与经验的报告方法： Value Health，2022，25（1）：3-9.
病例系列研究的设计和质量评价[J]. 中医杂志，2008，49 [118] MA L L，WANG Y Y，YANG Z H，et al. Methodological
（5）：407-410. quality （risk of bias） assessment tools for primary and
[105] FU S F，CHENG C W，ZHANG L，et al. Consensus-based secondary medical studies：what are they and which is
recommendations for case report in Chinese medicine better?[J]. Mil Med Res，2020，7（1）：7.
（CARC）[J]. Chin J Integr Med，2016，22（1）：73-79. [119] MUCKART D J J. Evidence-based medicine：are we boi-
[106] ZWARENSTEIN M，TREWEEK S，GAGNIER J J，et al. ling the frog?[J]. S Afr Med J，2013，103（7）：447-448.
Improving the reporting of pragmatic trials：an extension [120] MULROW C D. The medical review article：state of the
of the CONSORT statement[J]. BMJ，2008，337：a2390. science[J]. Ann Intern Med，1987，106（3）：485-488.
[107] DWAN K，LI T J，ALTMAN D G，et al. CONSORT 2010 [121] HIGGINS J P T，ALTMAN D G，GØTZSCHE P C，et al.
statement：extension to randomised crossover trials[J]. The cochrane collaboration’s tool for assessing risk of
BMJ，2019，366：l4378. bias in randomised trials[J]. BMJ，2011，343：d5928.
[108] VOHRA S，SHAMSEER L，SAMPSON M，et al. [122] STERNE J A C，SAVOVIĆ J，PAGE M J，et al. RoB 2：a
CONSORT extension for reporting N-of-1 trials （CENT） revised tool for assessing risk of bias in randomised trials
2015 statement[J]. BMJ，2015，350：h1738. [J]. BMJ，2019，366：l4898.
[109] GAGNIER J J，BOON H，ROCHON P，et al. Reporting [123] IBBOTSON T，GRIMSHAW J，GRANT A. Evaluation of
randomized，controlled trials of herbal interventions：an a programme of workshops for promoting the teaching of
elaborated CONSORT statement[J]. Ann Intern Med， critical appraisal skills[J]. Med Educ，1998，32（5）：
2006，144（5）：364-367. 486-491.
[110] CHENG C W，WU T X，SHANG H C，et al. CONSORT [124] PURSSELL E. Can the Critical Appraisal Skills Pro‐
extension for Chinese herbal medicine formulas 2017：re- gramme check-lists be used alongside grading of recom-
commendations，explanation，and elaboration：traditional mendations assessment，development and evaluation to
Chinese version[J]. Ann Intern Med，2017，167（2）：W7- improve transparency and decision-making? [J]. J Adv
W20. Nurs，2020，76（4）：1082-1089.
[111] LI J，HU J Y，ZHAI J B，et al. CONSORT extension for re‐ [125] TAYLOR R，REEVES B，EWINGS P，et al. A systematic
porting N-of-1 trials for traditional Chinese medicine review of the effectiveness of critical appraisal skills trai-
（CENT for TCM）：recommendations，explanation and ning for clinicians[J]. Med Educ，2000，34（2）：120-125.
elaboration[J]. Complement Ther Med，2019，46：180-188. [126] JADAD A R，MOORE R A，CARROLL D，et al. Asse-
[112] KWAKKENBOS L，IMRAN M，MCCALL S J，et al. ssing the quality of reports of randomized clinical trials：is
CONSORT extension for the reporting of randomised blinding necessary?[J]. Control Clin Trials，1996，17（1）：
controlled trials conducted using cohorts and routinely 1-12.

· 2364 · China Pharmacy 2025 Vol. 36 No. 19 中国药房 2025年第36卷第19期